For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Transforming growth factor beta 1 or TGF-ß1 is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation, and apoptosis. In humans, TGF-ß1 is encoded by the TGFB1 gene
Scope of the Report:
North America is the largest consumption place, with a consumption market share nearly 61.5% in 2017. Following North America, Asia-Pacific and Europe is the second two largest consumption places with the consumption market share of 18% and 17%, respectively.
The worldwide market for Transforming Growth Factor Beta 1 is expected to grow at a CAGR of roughly 11.3% over the next five years, will reach 1790 million US$ in 2024, from 1050 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Transforming Growth Factor Beta 1 in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
- Roche
- Shionogi Ltd
- Acceleron Pharma Inc
- Genzyme Corp
- Isarna Therapeutics GmbH
- Scholar Rock
- Sirnaomics Inc
- Eli Lilly and Co
- Formation Biologics Inc
- Novartis AG
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Pirfenidone
- Galunisertib
- Others
Market Segment by Applications, can be divided into
- IPF
- Cancer
- Others
There are 15 Chapters to deeply display the global Transforming Growth Factor Beta 1 market.
Chapter 1, to describe Transforming Growth Factor Beta 1 Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Transforming Growth Factor Beta 1, with sales, revenue, and price of Transforming Growth Factor Beta 1, in 2017 and 2018;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2017 and 2018;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Transforming Growth Factor Beta 1, for each region, from 2014 to 2019;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2014 to 2019;
Chapter 12, Transforming Growth Factor Beta 1 market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024;
Chapter 13, 14 and 15, to describe Transforming Growth Factor Beta 1 sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source